• Explore /
  • Poster
  • / Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort.

Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort.

Abstract Poster

Authors

null

Jackson Bowers

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Jackson Bowers , Jacob Anna , Steven Michael Bair , Kaitlin Annunzio , Narendranath Epperla , Jerrin Joy Pullukkara , Sameh Gaballa , Michael Spinner , Shuning Li , Marcus Messmer , Joseph Nguyen , Emily C. Ayers , Charlotte Burton Wagner , Boyu Hu , Mengyang Di , Scott F. Huntington , Fateeha Furqan , Nirav Niranjan Shah , Christina Chen , Jakub Svoboda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Hodgkin Lymphoma

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7542)

DOI

10.1200/JCO.2023.41.16_suppl.7542

Abstract #

7542

Poster Bd #

93

Abstract Disclosures

Similar Posters

First Author: Jane N. Winter

First Author: David J. Straus

First Author: Judah D. Friedman

First Author: Sharon M. Castellino